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Abstract 
 
Obesity is an epidemic causing significant 
morbidity and mortality in United States. It is 
facilitated by many factors including sedentary 
life style, abundance of food, and unhealthy 
dietary habits. This review aims to briefly 
address causes and conditions associated with 
obesity, with a special emphasis on reproductive 
performance for Obstetricians and 
Gynecologists. 
1Division of Reproductive Endocrinology and 
Infertility, Department of Obstetrics and 
Gynecology, Carver College of Medicine, 
University of Iowa Hospitals and Clinics, Iowa 
City, IA 
Definition of Obesity 
 
Obesity is defined by both National 
Institutes of Health (NIH) and World 
Health Organization (WHO)as having a 
body mass index (BMI) equal to or 
greater than 30 kg/m2.1,2 The degree of 
obesity is significantly associated with 
metabolic and cardiovascular co-
morbidities, including type 2 diabetes 
mellitus, hypertension, coronary heart 
disease, and sleep apnea (Table 1). 
Coexistence of these conditions will 
place patients in a very high-risk 
category for subsequent mortality.3 
Other morbidities associated with 
obesity include osteoarthritis, 
cholelithiasis, and impaired quality of 
life. Overall, obesity is associated with a 
striking reduction in life expectancy for 
both men and women, in younger and 
older ages.4,5 
 
Obesity is a chronic disease with 
increasing prevalence in adults, 
adolescents and children. It is now 
considered a global epidemic. In the 
United States, the lifetime risk of 
becoming overweight and obese is 
approximately 50% and 25%, 
respectively.6 As of 2009, overall self-
reported obesity prevalence in the 
United States was 26.7%, 
disproportionally affecting non-Hispanic 
blacks (36.8%), Hispanics (30.7%), 
those who did not graduate from high 
school (32.9%), and people aged 50-59 
years (31.1%) and 60-69 years (30.9%) 
(Figure 1).7 Healthcare expenses are 
significantly higher for overweight and 
obese individuals, and on average, 
obese people have medical costs that 
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are $1,429 more than non-obese 
people, translating to an estimated 
annual cost of $147 billion in the United 
States.
 
Table 1: Classification of obesity 
WHO Class Popular Description BMI (kg/m2) Co-morbidities 
Underweight Thin <18.5 Other clinical problems 
Normal range Normal 18.5-24.9 Average 
Overweight    
 Pre-obese Overweight 25.0-29.9 Increased 
 Obese Class I Obese 30.0-34.9 Moderate 
 Obese Class II Obese 35.0-39.9 Severe 
 Obese Class III Morbidly obese >40.0 Very severe 
 
Figure 1: Prevalence of obesity in US adults by state in 20091 
1Centers for Disease Control and Prevention. U.S.  Obesity Trends:  Trends by State 1985–2009.  
http://www.cdc.gov/obesity/data/trends.html.  March 2011.  
Physiologic Basis for Obesity 
 
Simply put, energy intake needs to be 
higher than energy expenditure for an 
increase in body fat. However, there is a 
feedback between energy intake and 
expenditure in biological systems, which 
is affected by several factors including 
intrauterine growth and growth and 
reproductive hormones.  This 
complicated modulation of energy 
utilization and storage reduces the initial 
statement of the first law of 
thermodynamics to an 
oversimplification. The body typically 
responds to a 10-20% loss in weight by 
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decreasing total and resting energy 
expenditures; weight gain is associated 
with an increase in energy expenditure, 
which retards further weight gain.8 
Therefore, organisms seem to have a 
mechanism that tries to maintain 
bodyweight, indicating that behavior 
may not be the sole determinant of 
obesity. 
 
Approximately 70% of energy 
expenditure is utilized for basal or 
resting metabolic processes, 10% is 
dissipated through the thermic 
responses to food, and the remaining 
component is attributed to activity and 
exercise.9 Spontaneous activity 
(fidgeting) can account for an 
expenditure of up to 800 kcal daily and, 
along with the genetic factors, is 
responsible for much of the variance in 
energy expenditure among individuals. 
A simplified schematic representation of 
energy regulation is presented in Figure 
2.10 Afferent signals provide information 
about the deficits or excesses of 
nutrients and also include neural circuits 
and circulating hormones, such as 
leptin, ghrelin, obestatin, and glucagon-
like-peptide-1. Regions of the brain that 
process this information are the nucleus 
of the tractus solitarius, the arcuate 
nucleus, the paraventricular nucleus, the 
ventromedial hypothalamus, the lateral 
hypothalamus, and selected regions of 
the amygdala. A variety of monoamines, 
including norepinephrine and serotonin, 
and hormones play various roles in this 
system. Among these, neuropeptide Y, 
ghrelin, dynorphin, melanin-
concentrating hormone, growth 
hormone-releasing hormone, 
norepinephrine, orexin-A, and orexin-B 
act as appetite enhancers. In contrast, 
cholecystokinin, enterostatin, and 
peptide YY 3-36 suppress food intake. 
The sympathetic nervous system and 
glucocorticoids also act as components 
of the efferent signaling system, 
affecting food intake and adipose tissue 
metabolism. Leptin is the principal 
afferent signal that provides information 
about the amount of stored energy in 
adipose tissue. 
Pathogenesis of Obesity 
 
Obesity has many causes with variable 
genetic components.11 Twins raised 
separately still inherit obesity, although 
to a lesser extent than when raised 
together.12 Similarly, adoptees’ BMIs 
correlate with that of their biological 
parents rather than that of their adoptive 
parents.13 In addition to weight, 
metabolic rate, thermic response to 
food, and spontaneous physical activity 
are to some extent heritable.14 
 
Several genetic disorders present with 
obesity; some are inherited as 
autosomal dominant, some are 
autosomal recessive, whereas others 
are X-linked.11 The Bardet-Biedl and 
Prader-Willi syndromes are probably the 
best known examples of these traits. 
Bardet-Beidl syndrome is an autosomal 
recessive disorder characterized by 
obesity, hypogenitalism in men, mental 
retardation, retinal dystrophy, 
polydactyly, and renal malformations.15 
At least 10 genetic loci have been 
identified in patients with this syndrome. 
Prader-Willi syndrome, on the other 
hand, is caused either by a deletion of 
paternal DNA in the long arm of 
chromosome 15 (q11-13), or by the 
presence of two copies of maternal 
chromosome 15 (uniparental 
disomy).16,17  Affected patients have 
poor muscle tone, a history of poor 
feeding in the newborn period, a 
voracious appetite later in life, 
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behavioral problems (irritability, 
tantrums), delayed development, short 
stature, and hypogonadotropic 
hypogonadism with a common 
occurrence of cryptorchidism in boys 
and primary amenorrhea in girls.18 
Despite the well-defined nature of these 
genetic syndromes, they are rare and 
genes contributing to the more common 
forms of obesity are yet to be 
determined. Several candidate genes 
have been identified and are currently 
under investigation with the hopes of 
understanding the causes of the more 
common types of obesity. 
Obesity Risk Factors 
 
The risk factors associated with a high 
risk of obesity can be roughly 
categorized as metabolic and 
socioeconomic. Metabolic factors 
include a low metabolic rate, increased 
carbohydrate oxidation, insulin 
resistance, and low sympathetic activity. 
Socioeconomic factors include a lower 
socioeconomic class, a lower education 
level, and cessation of smoking.19,20 
 
There are several predictors of obesity 
starting from the prenatal period to 
adulthood. Infants born to women with 
diabetes and infants born to women who 
smoked during pregnancy are at greater 
risk for obesity later in life. Similarly, 
both infants born small for gestational 
age and those in the top 10th percentile 
of birth weight are at greater risk for 
obesity. Breastfeeding for three or more 
months seems to be a good preventive 
strategy to prevent obesity later in life.21 
A list of risk factors identified to predict 
development of obesity is presented in 
Box 1.22 
 
Figure 2: Feedback model for body energy regulation (modified from reference (10)) 
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Table 2: Drugs causing weight gain and their alternatives  
Category Drug Alternative 
Neuroleptics Thioridazine, olanzapine, 
quetiapine, risperidone, 
clozapine 
Molindone, haloperidol, 
aripiprazole 
Antidepressants   
 Tricyclics Amitriptyline, nortriptyline, 
imipramine 
Protriptyline 
 SSRI Paroxetine Sertraline, fluoxetine 
 Other Mitrazapine Bupropion, nefazodone 
Anticonvulsants Valproate, carbamazepine, 
gabapentin 
Topiramate, lamotrigine, 
zonisamide 
Antidiabetics Insulin, sulfonylureas, 
thiazolidinediones 
Acarbose, miglitol, metformin, 
pramlintide, exenatide 
Antiserotonins Pizotifen - 
Antihistamines Cyproheptadine Inhalers, decongestants 
β-blockers Propranolol, atenolol, 
metoprolol 
ACE inhibitors, Ca channel 
blockers 
α-blockers Terazosin ACE inhibitors, Ca channel 
blockers 
Steroid hormones Corticosteroids, progestins - 
Adapted from (22). Abbreviations: MOA,monoamine oxidase; SSRI, selective serotonin uptake inhibitors  
 
Box 1: Risk factors for development of obesity 
Risk Factors 
• Infants born to women who smoked during pregnancy 
• Infants born to women with diabetes 
• Multiple births 
• Premature births 
• Small for gestational age infants 
• Large for gestational age infants 
• Recent marriage 
• Smoking cessation 
• Parental overweight 
• Lower socioeconomic status 
• Overweight during childhood or adolescence 
• Lack of maternal knowledge of child’s sweet-eating habits 
• Low level of physical activity 
• High intake of dietary fat 
• Infants breastfed for less than 3 months 
• Pregnancy 
• Menopause 
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Conditions Causing Obesity 
 
Other than the well-defined genetic 
syndromes some of which were stated 
above, there are several clinical entities 
that may result in obesity without 
producing distinctive phenotypes. 
1. Neuroendocrine Obesity 
a) Hypothalamic Obesity 
Hypothalamic obesity may be produced 
in animals by injuring the ventromedial 
or paraventricular region of the 
hypothalamus or the amygdala, but it is 
rare in humans. It may be caused in 
humans by trauma, tumor, inflammatory 
disease, surgery in the posterior fossa 
or increased intracranial pressure. 
b) Cushing’s syndrome 
Obesity is a major feature of Cushing’s 
syndrome. However, a variety of 
conditions may mimic Cushing’s 
syndrome by distorting the 
hypothalamic-pituitary-adrenal axis; 
manifestations include depression, 
anxiety disorder, obsessive-compulsive 
disorder, poorly controlled diabetes, and 
alcoholism, and the condition is referred 
to as pseudo-Cushing’s syndrome. 
Although it may be challenging at times 
to differentiate these two conditions from 
each other, it is necessary to address 
the underlying problem appropriately. 
c) Hypothyroidism 
Weight gain associated with 
hypothyroidism is secondary to the 
slowing metabolic activity and typically 
does not lead to marked obesity. It is 
more prevalent in older women. 
a) Polycystic Ovary Syndrome 
Polycystic ovarian syndrome (PCOS) is 
a spectrum of conditions characterized 
by menstrual irregularities, 
hyperandrogenism and/or 
ultrasonographic appearance of 
polycystic ovaries.23 It is believed to 
affect 6-8% of all women.24,25 
Approximately 60% of women in United 
States with PCOS are obese.26 Similarly, 
50-70% of women with PCOS have 
clinically measurable insulin resistance 
in vivo, which is more than what is 
determined by their body weight. It is 
clear that environmental factors play 
part in determining the presence and 
degree of obesity in PCOS; however it is 
also possible that PCOS is associated 
with a greater propensity for obesity and 
weight gain. 
d) Growth Hormone Deficiency 
Growth hormone selectively decreases 
visceral fat and may be a factor in the 
age-related increase in visceral fat since 
the level of growth hormone gradually 
decreases with age. Women and 
children with growth hormone deficiency 
exhibit an increase in visceral fat, 
although this increase does not lead to 
clinical obesity. 
2. Drug Induced Weight Gain 
 
A brief list of drugs that may cause 
weight gain is presented in Table 2.22 
Most of these medications are not 
sufficient to cause obesity on their own, 
except high dose corticosteroids, 
psychoactive drugs or valproate. 
3. Cessation of Smoking 
Weight gain after cessation of smoking 
is common and at least partly mediated 
by nicotine withdrawal.27,28 The odds 
ratio of obesity by smoking cessation is 
estimated to be 2.4 in men and 2.0 in 
women. Therefore, all patients who plan 
to quit smoking should consider an 
exercise program and decreased caloric 
intake. 
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4. Sedentary Life Style 
 
Restriction of physical activity is 
probably the most important contributor 
to obesity, even more so than increased 
food intake. The highest frequency of 
overweight individuals occurs in those 
persons with sedentary occupations. 
Low levels of physical activity and 
recreation are related to weight gain.29 
In addition, high levels of physical 
activity are required to maintain normal 
body weight in middle age years.30 
Similarly, BMI of children is positively 
correlated with the hours spent watching 
television.31 Just reducing TV viewing, 
without any other intervention, 
significantly reduces BMI in children.32 
 
5. Dietary Factors 
 
Excess energy intake in relation to 
energy expenditure is the basis for 
development of obesity. Several dietary 
factors that may impact this balance are 
listed below. 
a) Overeating 
Voluntary overeating is one cause of 
excess energy intake. Some individuals 
may actually lose all the weight they 
have gained once they stop overeating, 
whereas for others weight gain can 
reach a rate of nearly 25 kg/year and is 
sustained until death. 
b) Fat Intake 
High fat content in a diet is associated 
with obesity, as indicated by a positive 
correlation between relative weight in 
several populations and the percentage 
of fat in their diets.33 A high-fat diet 
provides a high energy density (i.e., 
lesser weight of food for the same 
amount of calories), which makes 
overconsumption more likely. 
c) Carbohydrate and Fiber Intake 
The glycemic index is a measure of the 
effects of carbohydrates on blood sugar 
levels. Carbohydrates that break down 
quickly during digestion and release 
glucose rapidly into the bloodstream 
have a high glycemic index; 
carbohydrates that break down more 
slowly, releasing glucose more gradually 
into the bloodstream, have a low 
glycemic index. It has been documented 
that the consumption of foods with a 
high glycemic index is associated with 
higher energy intake than when the 
foods have a low glycemic index.34 
Foods with low glycemic index also 
stimulate less food intake. Consumption 
of sugar-sweetened beverages, which 
typically have a high glycemic index, by 
children may enhance the risk of rapid 
weight gain. 35 
d) Calcium Intake 
Low calcium intake may facilitate weight 
gain. Increasing supplemental calcium 
from 0 mg to nearly 2,000 mg daily was 
associated with a reduction in BMI of 
approximately 5 units.36 
e) Frequency of Eating 
Although not completely established, 
eating bigger portions less often seems 
to cause weight gain more than eating 
smaller portions more frequently. One 
explanation to this observation may be 
the greater insulin secretion associated 
with eating larger meals. 
f)  Restrained Eating 
Restrained eating is a common practice 
in many, if not most, middle-aged 
women of normal weight, characterized 
by conscious limitation of food intake. 
Greater increases in restraint correlate 
with greater weight loss but also with a 
higher risk of lapses, loss of control, and 
overeating. 
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g) Binge Eating Disorder 
Binge eating disorder is a psychiatric 
illness that primarily affects women. It is 
characterized by uncontrolled episodes 
of usually evening time eating. 
h) Night-Eating Syndrome 
Night-eating syndrome is the 
consumption of at least 25% of the total 
daily energy consumed between the 
evening meal and the following morning. 
It may be related to sleep disturbances, 
and may be a component of sleep 
apnea. 
6. Psychological and Social Factors 
 
Seasonal affective disorder is a type of 
depression that occurs during the winter 
in some individuals living in the north, 
possibly associated with shorter days. 
Patients with this condition have a 
tendency to gain weight during the 
winter. It can be treated effectively by 
high intensity artificial light in the winter. 
Attempts to link a personality type to the 
development of obesity have been 
unsuccessful. 
7. Socioeconomic and Ethnic Factors 
 
Obesity is more prevalent in lower 
socioeconomic groups in the United 
States. Although African-American 
women of all ages are more obese than 
Caucasian women, the association 
between socioeconomic status and 
being overweight or obese is much 
greater in the latter group. The 
relationship between the socioeconomic 
status and obesity is generally far less 
pronounced in men.37 
Conditions Associated with Obesity  
 
Obesity is estimated to be responsible 
for approximately 100,000-300,000 
deaths annually in the United States. A 
Prospective Studies Collaboration 
analysis of 57 prospective studies, 
where 894,000 individuals were followed 
for a mean of eight years, showed that 
mortality is lowest among men and 
women with a BMI between 22.5 and 25 
kg/m2, and there is a 30% increase in 
overall mortality for each 5 kg/m2 
increase in BMI.3 Obesity-related deaths 
are mostly caused by increased deaths 
from heart disease, diabetes, 
hypertension and cancer. 
1. Morbidity Related to Adipose 
Tissue Hyperplasia / Hypertrophy 
 
These conditions can be listed as 
metabolic syndrome, diabetes, 
cardiovascular disease and 
hypertension, gallbladder disease, and 
cancer. Specifically, central obesity has 
been associated with an inflammatory 
milieu, which may lead to insulin 
resistance, impaired glucose tolerance 
or diabetes, dyslipidemia, including high 
levels of triglycerides and markers of 
inflammation (e.g. C-reactive protein), 
hyperuricemia, hypertension, impaired 
coagulation, and vasculoendothelial 
dysfunction. Weight loss of ~16% in 
obese individuals dramatically increases 
recovery from many of these 
conditions,38 and beneficial effects start 
to be seen by losing as low as 10 lbs. In 
addition, the prevalence of gall stones 
sharply increases with weight gain, 
which may be a product of increased 
cholesterol levels and excretions serving 
as nidation factors for stone formation in 
the gallbladder. Furthermore, rates of 
cancer of the endometrium, breast, 
colon, and gallbladder are increased in 
obese women. This is explained in part 
by increased aromatization of 
androgens into estrogens, which serve 
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as a mitogenic factor for some of these 
tissues, by the adipose tissue. 
2. Morbidity Attributed Directly to Fat 
Tissue 
 
Sleep apnea is prevalent in 
overweight/obese individuals, 
characterized by intermittent airway 
obstruction that interrupts sleep and 
causes hypoxemia. Increased fat mass 
in the pharyngeal area is one 
explanation for this condition. 
Degenerative osteoarthritis is one of the 
most costly and debilitating 
consequences of obesity, and generally 
progresses with age. Social 
stigmatization is another direct 
consequence of obesity, which probably 
affects women more than men, creating 
self-confidence and quality of life 
problems. 
Reproductive Performance 
 
Many studies have reported an 
association between increased BMI and 
infertility, most commonly related to 
ovulatory dysfunction, although 
decreased spontaneous pregnancy 
rates and increased time to pregnancy 
was also reported even among 
ovulatory obese women.39, 40, 41 Obesity 
may also have a negative impact on the 
outcome of treatment of infertility. Some 
studies show poorer outcomes of 
infertility treatment in these women,42 
while others suggest that outcomes are 
comparable to non-obese women but 
higher doses of ovulation-inducing 
agents need to be used.43,44 A 
systematic review of 11 observational 
studies addressed the impact of obesity 
on the outcome of assisted reproductive 
technologies, i.e., in vitro fertilization. 
Overall, overweight women had a lower 
likelihood of pregnancy, increased risk 
of miscarriage, reduced number of 
oocytes retrieved, and higher doses of 
gonadotropins were needed. In this 
review, there was insufficient evidence 
for a correlation between obesity and 
live birth and cycle cancellation rates, as 
well as ovarian hyperstimulation 
syndrome development rate,45 although 
individual studies reported conflicting 
results.46,47,48 
 
Obesity is associated with various 
complications during pregnancy, 
including gestational and overt diabetes, 
pregnancy associated hypertension, 
preterm delivery, postterm pregnancy, 
urinary tract infections, and sleep 
apnea. It is logical to consider the 
combination of two hypercoagulable 
states, pregnancy and obesity, as a 
compounded hypercoagulable and 
prothrombotic state.49 Obese women 
have longer labors characterized by 
prolongation of the active phase of 
labor, are more likely to have labor 
induction,50,51,52 are more likely to fail 
vaginal birth attempt after cesarean 
delivery with an increased risk of uterine 
dehiscence/rupture, 53,54,55,56 and are 
more likely to have macrosomic infants 
with associated intrapartum 
complications (shoulder dystocia, 
malpresentation, hemorrhage, and 
fourth degree laceration).57,58,59,60 There 
are many intra- and post-operative 
concerns surrounding cesarean delivery 
with obese women, including 
emergency delivery, prolonged incision-
to-delivery interval, blood loss >1000 ml, 
longer operative times, among 
others.53,57,58,61,62 The type of incision 
should be decided carefully secondary 
to the presence of large pannus and 
caudal displacement of umbilicus. 
Complications due to anesthesia are 
more common, both for regional 
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(challenging placement of spinal 
anesthesia or epidural catheter) or 
general anesthesia (challenging 
endotracheal intubation, increased risk 
of aspirating stomach contents, avoiding 
premature extubation).62,63,64,65 Obese 
gravid is at higher risk for postpartum 
infection (wound, episiotomy, and 
endometritis) regardless of the mode of 
delivery and despite the use of antibiotic 
prophylaxis.57,58,59,62,66,67  There are 
conflicting data about the effect of 
obesity on lactation and postpartum 
bleeding. Some studies suggested an 
increased risk of failure to initiate 
lactation and a decreased duration of 
lactation in obese women,68,69,70,71,72 
whereas others failed to identify a 
similar relationship.73,74 Similarly, a large 
population-based cohort study reported 
a 44% increased risk for major 
postpartum hemorrhage in obese 
gravidas,57 whereas several small 
studies did not find such an 
association.59,75,76 
Maternal obesity is associated with a 
small increase in the absolute rate of 
some congenital anomalies, including 
neural tube defects, cardiovascular 
anomalies, cleft lip and palate, anorectal 
atresia, hydrocephaly, and limb 
reduction anomalies, whereas the risk of 
gastroschisis was significantly 
reduced.77,78,79 Also, the typical 
reduction in neural tube defect risk 
associated with standard doses of folic 
acid supplementation was reported to 
not occur in obese women.80 There are 
several confounders that may have an 
impact on these findings. Among those 
are increased prevalence of diabetes 
among obese women, and increased 
difficulty in diagnosing congenital 
anomalies in obese women, probably 
leading to more affected liveborns in this 
population. Risk of stillbirth and neonatal 
death were also reported to be higher in 
obese women.81,82 In addition to 
shoulder dystocia, fetal macrosomia 
may also predispose the neonate to 
obesity later in life, based on 
epidemiologic studies.83,84,85,86 
For prevention of obesity-related 
complications during pregnancy, the 
best strategy is weight loss before 
conception. Despite the challenges 
associated with weight loss, it should 
continue to be encouraged as a primary 
preventive strategy in this population. 
Conclusions and Comments 
 
Obesity is an epidemic fueled by 
sedentary life style, abundance of food, 
unhealthy dietary habits, and other 
factors. Epidemiologic indicators predict 
worsening of the situation in the 
forthcoming years, leading to a chain 
reaction of increases in several 
morbidities and mortality. Prevention is 
the best strategy to avoid morbidity and 
mortality associated with obesity. 
Obstetricians and gynecologists have a 
unique position in this respect. As a 
primary care provider, he/she can not 
only use the regular office visit as an 
opportunity to screen for obesity and 
encourage proper diet, physical activity, 
and weight control, but also help 
manage underlying disorders that lead 
to obesity. Preconceptional visits are 
another excellent opportunity to help an 
overweight woman begin a weight loss 
program before she gets pregnant. By 
doing so, both maternal and fetal health 
may be protected and improved, 
allowing a better start and a healthier life 
for future generations. 
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